我院2017-2019年司琼类药物临床应用分析  

Clinical Application Analysis of Setrons in Our Hospital from 2017 to 2019

作　　者：刘祖祥[1] 屠文莲[1] 曹玮[1] Liu Zuxiang;Tu Wenlian;Cao Wei(Department of Pharmacy,The First People s Hospital of Yunnan Province,Kunming 650032,China)

机构地区：[1]云南省第一人民医院药学部,昆明650032

出　　处：《大理大学学报》2021年第8期39-43,共5页Journal of Dali University

摘　　要：目的:了解云南省第一人民医院(以下简称“我院”)司琼类药物使用情况及用药趋势,为临床合理使用该类药品提供参考。方法:选取我院2017—2019年“医院信息管理系统(HIS)”中使用司琼类药物的电子病历300例,从使用品种、销售金额、用药频度(DDDs)、限定日费用、不合理用药等方面进行分析。结果:我院司琼类药物销售金额、DDDs排名第1位的品种均为托烷司琼注射液。司琼类药物不合理用药49例,占16.33%。结论:我院司琼类药物的使用量逐年增加,用药趋势基本符合治疗需求,但尚存在剂型及品种配备不全的问题需要改进。Objective:To understand the use and trend of setron drugs in the First People s Hospital of Yunnan Province(hereinafter referred to as“our hospital”),and provide references for the rational use of such drugs in clinical practice.Methods:The electronic medical records of 300 cases of setrons used in our hospital information management system(HIS)from 2017 to 2019 were selected and analyzed from the aspects of variety,sales amount,frequency of drug use(DDDs),daily average cost and unreasonable use of drugs,etc.Results:Tropisetron injection ranked first in sales sum and DDDs.There were 49 cases of irrational use of the drug,accounting for 16.33%of the total cases.Conclusion:The use of setron drugs in our hospital is increasing year by year,and the trend of drug use basically meets the needs of treatment,but the problem of incomplete dosage forms and varieties needs to be improved.

关 键 词：司琼类药物 用药频度 限定日费用 合理用药 

分 类 号：R969.3[医药卫生—药理学]